去查网 logo

Tuvirumab

中文翻译妥韦单抗

同义词释义

    1)Tuvirumab,妥韦单抗2)Sevirumab,司韦单抗3)Cetuximab,西妥昔单抗4)Rituximab,利妥昔单抗5)Trastuzumab,曲妥珠单抗6)pertuzumab,帕妥株单抗

用法例句

    Evaluation of Cetuximab in combination with radiotherapy or chemotherapy against advanced squamous cell carcinoma of the head and neck;

    西妥昔单抗联合化疗或放疗治疗晚期头颈鳞癌的疗效评价(英文)

    Effects of Cetuximab Combined Erlotinib on Proliferation of Human Hepatocellular Carcinoma Cell Lines HepG2 and Bel-7402;

    西妥昔单抗联合厄洛替尼对人肝癌细胞的体外抑制作用

    Clinical observation of combination chemotherapy for metastatic colorectal cancer with Cetuximab;

    西妥昔单抗联合化疗治疗转移性结直肠癌的临床观察

    Effectiveness and pharmacoeconomic evaluation of rituximab for treatment of non-Hodgkin s lymphoma;

    利妥昔单抗对于非霍奇金淋巴瘤的治疗及其药物经济学

    Rituximab in Combination with CHOP Scheme for Non-Hodgkin s Lymphoma: Evaluation of Clinical Efficacy;

    利妥昔单抗联合CHOP方案治疗NHL的临床疗效评价

    Expression of CD16ζ in NK Cells of B-cell Non-Hodgkin s Lymphoma Patients and In Vitro Killing Effect of Rituximab Combined Lymphokine-activated Killer Cells on B-NHL Cells;

    B-NHL患者NK细胞中CD16ζ表达及利妥昔单抗与LAK细胞的联合抗瘤作用

    Advances in resistance mechanisms of trastuzumab HER2 monoclonal antibody;

    HER2单抗曲妥珠单抗耐药机制研究进展

    Results of Two Open-label, Multicenter Phase Ⅱ Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER-2 Positive Advanced Breast Cancer;

    多西他赛、铂盐加曲妥珠单抗在HER-2阳性进展期乳腺癌中的两个开放、多中心的Ⅱ期研究结果

    Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinoma;

    曲妥珠单抗每三周方案联合紫杉醇治疗HER-2阳性转移性乳腺癌的药代动力学、安全性及有效性研究

    Bacterial Endotoxin Test of Cetuximab Injection

    西妥昔单抗注射液细菌内毒素检查法

    A experimental study on inhibiting effect of cetuximab on angiogenesis

    西妥昔单抗抑制血管生成的实验研究

    Cetuximab plus chemotherapy in the treatment of patients with head and neck squamous cell carcinomas (HNSCC)

    西妥昔单抗联合化疗治疗头颈部鳞癌初步研究

    Cetuximab for the treatment of metastatic colorectal cancer:a meta-analysis

    西妥昔单抗治疗转移性结直肠癌的荟萃分析

    Cetuximab plus chemotherapy agents in the treatment of metastic colorectal cancer and literature review

    西妥昔单抗联合化疗治疗转移性结直肠癌

    Antitumor Activities of Cetuximab in Combination with Radiotherapy in Human Gastric Carcinoma Cell Lines MGC803 and BGC823;

    西妥昔单抗联合放疗对人胃癌细胞株MGC803及BGC823抑制作用的研究

    Apoptosis Induced by Cetuximab in Conjunction with Hyperthermia and Radiotherapy in Human NPC CNE Cell Line

    西妥昔单抗联合热疗及放疗诱导人鼻咽癌细胞株CNE凋亡实验研究

    Clinical Research of Cetuximab Combined with Chemotherapy in Treating Metastatic Colorectal Cancr

    西妥昔单抗联合化疗治疗转移性结直肠癌的临床研究

    K-ras status and efficacy of cetuximab-containing regimen in the treatment of patients with metastatic colorectal cancer

    西妥昔单抗联合化疗治疗转移性结直肠癌疗效与K-ras状态的关系

    Efficacy of cetuximab combined with chemotherapy on advanced colorectal cancer:a report of 53 cases

    西妥昔单抗联合化疗对53例晚期结直肠癌的疗效

    Clinical observation on cetuximab plus chemotherapy in treatment of advanced metastatic colorectal cancer

    西妥昔单抗联合化疗治疗晚期结直肠癌的临床观察

    Cetuximab plus FOLFIRI for patients with advanced colorectal cancer

    西妥昔单抗联合FOLFIRI方案治疗晚期大肠癌的临床观察

    The clinical observation of cetuximab in combination with chemotherapy in metastatic colorectal cancer patients

    西妥昔单抗联合化疗治疗转移性结直肠癌的临床观察

    Exprimental research on K-ras mutation and the resistance to cetuximab

    结肠癌K-ras突变与对西妥昔单抗耐药的实验研究

    Inhibition effects of cetuximab in human nasopharyngeal carcinoma cells in vitro

    西妥昔单抗对人鼻咽癌细胞抑制作用的体外研究

    KRAS Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

    西妥昔单抗治疗进展性结直肠癌的疗效与KRAS基因突变状态的关系

    Prediction for Cetuximab Combination with FOLFOX4 Regimen in the First-Line Treatment of Metastatic Colorectal Cancer

    西妥昔单抗联合FOLFOX4方案在转移性结直肠癌一线治疗的疗效预测

    Concurrent Cetuximab and Irradiation for Squamous Cell Carcinoma of the Head and Neck in Vitro

    西妥昔单抗联合放疗对头颈鳞癌体外治疗的研究

全部查询工具

关于我们免责声明联系我们网站地图最近更新

免责说明:本站为非营利性网站,本站内容全部由《去查网》从互联网搜集编辑整理而成,版权归原作者所有,如有冒犯,请联系我们删除。

Copyright © 2020 - 2024 quchaw.com All rights reserved.浙ICP备20019715号